A Propsective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis during Peripheral Vascular Surgery

StatusActive
Effective start/end date18/02/1528/02/20

Funding

  • Grifols, Inc: $17,661.00

Keywords

  • Biotechnology & Drug Development, Cardiovascular Research